首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1472篇
  免费   78篇
  国内免费   4篇
耳鼻咽喉   15篇
儿科学   84篇
妇产科学   35篇
基础医学   168篇
口腔科学   45篇
临床医学   116篇
内科学   327篇
皮肤病学   29篇
神经病学   59篇
特种医学   422篇
外科学   93篇
综合类   43篇
预防医学   28篇
眼科学   10篇
药学   47篇
  1篇
肿瘤学   32篇
  2018年   9篇
  2017年   14篇
  2016年   10篇
  2015年   14篇
  2014年   30篇
  2013年   32篇
  2012年   17篇
  2011年   20篇
  2010年   36篇
  2009年   54篇
  2008年   21篇
  2007年   36篇
  2006年   27篇
  2005年   23篇
  2004年   17篇
  2003年   17篇
  2002年   9篇
  2001年   17篇
  2000年   9篇
  1999年   17篇
  1998年   79篇
  1997年   81篇
  1996年   81篇
  1995年   66篇
  1994年   41篇
  1993年   62篇
  1992年   6篇
  1991年   11篇
  1990年   25篇
  1989年   54篇
  1988年   43篇
  1987年   47篇
  1986年   52篇
  1985年   69篇
  1984年   35篇
  1983年   29篇
  1982年   28篇
  1981年   31篇
  1980年   37篇
  1978年   19篇
  1977年   23篇
  1976年   21篇
  1975年   20篇
  1959年   7篇
  1958年   28篇
  1957年   22篇
  1956年   23篇
  1955年   16篇
  1954年   16篇
  1948年   9篇
排序方式: 共有1554条查询结果,搜索用时 0 毫秒
81.
82.
83.
84.
Finn  EJ; Di Chiro  G; Brooks  RA; Sato  S 《Radiology》1985,156(1):139-141
A number of surgical clips and other metallic materials embedded within patients have ferromagnetic properties that present a potential hazard when in the strong fields associated with magnetic resonance imaging. Several types of magnetometers and metal detectors were investigated as possible pre-imaging screening devices. The sensitivities and costs of these devices are given.  相似文献   
85.
Wienke A 《HNO》2005,53(5):467-472
Ohne Zusammenfassung
Current aspects of forensic lawFrom October 2004 to March 2005
  相似文献   
86.
目的:高血压常伴有纤溶功能的异常,但其机制尚不清楚。本研究拟观察高静水压培养对人脐静脉内皮细胞(HUVECs)t-PA和PAI-1的影响以及卡托普利的干预效果,并探讨其可能的作用机制。方法:选用第4~6代HU-VECs,接种于24孔培养板中。依培养压力分为3组:大气压组(0mmHg),中压组(90mmHg),高压组(180mmHg)。在同一压力组,根据不同药物干预又分为两个亚组。即对照组(Ctrl)和卡托普利组(Cap,10^-5mol/L)。每组6份标本。采用ELISA法测定上清液t-PA和PAI-1的抗原浓度,并用细胞内总蛋白进行标化(单位:ng/μg proteins)。同时测定细胞内Ca^2+浓度(nmol/L)。结果:与大气压组相比,中压和高压组t-PA浓度均显著降低,PAI-1浓度显著增高,t-PA/PAI-1比值显著降低,[Ca^2+]i也显著增高。卡托普利对大气压组的t-PA、PAI-1和[Ca^2+]i无显著影响,但在两个高压组,卡托普利显著升高t-PA浓度,显著降低PAI-1浓度,t-PA/PAI-1比值显著升高,[Ca^2+]i显著地降低。结论:高静水压可损害内皮细胞的纤溶功能,而卡托普利的干预可降低高压所升高的[Ca^2+]i,并改善高静水压对内皮细胞纤溶功能的影响。  相似文献   
87.
Background--Currently, the reporting and archiving of echocardiographic data suffer from the difficulty of representing heart motion on printable 2-dimensional (2D) media. Methods and Results--We studied the capability of holography to integrate motion into 2D echocardiographic prints. Images of normal human hearts and of a variety of mitral valve function abnormalities (mitral valve prolapse, systolic anterior motion of the mitral leaflets, and obstruction of the mitral valve by a myxoma) were acquired digitally on standard echocardiographic machines. Images were processed into a data format suitable for holographic printing. Angularly multiplexed holograms were then printed on a prototype holographic "laser" printer, with integration of time in vertical parallax, so that heart motion became visible when the hologram was tilted up and down. The resulting holograms displayed the anatomy with the same resolution as the original acquisition and allowed detailed study of valve motion with side-by-side comparison of normal and abnormal findings. Comparison of standard echocardiographic measurements in original echo frames and corresponding hologram views showed an excellent correlation of both methods (P<0.0001, r2=0.979, mean bias=2.76 mm). In this feasibility study, both 2D and 3D holographic images were produced. The equipment needed to view these holograms consists of only a simple point-light source. Conclusions--Holographic representation of myocardial and valve motion from echocardiographic data is feasible and allows the printing on a 2D medium of the complete heart cycle. Combined with the recent development of online holographic printing, this novel technique has the potential to improve reporting, visualization, and archiving of echocardiographic imaging.  相似文献   
88.
Eight cases of dermatomyositis in children admitted to Scottish hospitals between 1962 and 1972 have been reviewed. 6 of the 8 were currently in complete remission. In the other 2 cases the disease remained active in 1 and 1 had died of cardiac failure 6 years after the onset of disease. 5 had developed extensive soft tissue calcification for which 2 were treated with ethanehydroxydiphosphonate, one showing definite improvement and the other no change. All had been treated with corticosteroids and two in addition had had cytotoxic agents (methotrexate or cyclophosphamide). The overal prognosis had probably been improved by the use of corticosteroids but not by the cytotoxic drugs. Only one of the patients was incapacitated by residual contractures or calcinosis.  相似文献   
89.
40年前创立的青少年糖尿病研究基金会((JDRF)是一个致力于通过支持研究来探寻1型糖尿病(TIDM)及其并发症治疗方法的组织.20世纪70年代有学者提出,TIDM和2型糖尿病(T2DM)的发病机制有根本的不同,T1DM与主要组织相容性复合体的人白细胞抗原(HLA)有独特相关性,有胰岛细胞自身抗体.  相似文献   
90.
At birth, premature infants of 25-29 weeks gestation, at high risk for development of neonatal respiratory distress syndrome (RDS), were given a single dose (90 mg) of calf lung surfactant extract (CLSE) by intratracheal instillation. The frequency and severity of RDS were assessed with use of a simple radiographic scoring system in which pulmonary parenchymal densities and the prominence of the air-bronchogram effect were used as indicators of widespread atelectasis. Radiographs were obtained in surfactant-treated and control infants within the first 90 minutes of life as part of an initial evaluation of their pulmonary status. Subsequent examinations were performed at less than 24 hours and less than 48 hours of age. Radiographic assessment of lung disease compared consistently with coordinated data on oxygen and mean airway pressure requirements of the infants. Both indicated a significantly decreased frequency and severity of RDS in the infants treated with surfactant. The results provide supporting evidence of the effectiveness of exogenous lung surfactant replacement in mitigating RDS in very premature infants.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号